Clinical trial

Comparative Effectiveness and Safety of Tiotropium and Olodaterol in Comparison to LABA/ICS

NCT04138758

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2019-11-01

PhaseN/A

Study timeline

Study start (actual)2019-11-01Date precision: day

Registry last updated2021-11-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

COPDunresolved

Interventions

Tiotropium bromide + OlodaterolDRUG

LABA/ICSDRUG

Sponsors & collaborators

Boehringer Ingelheimlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04138758 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.